Navigation Links
IPC The Hospitalist Company, Inc. Provides Second Quarter 2008 Outlook
Date:6/17/2008

NORTH HOLLYWOOD, Calif., June 17 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national hospitalist physician group practice, today announced that it continues to experience favorable trends in patient encounters and expects second quarter 2008 net revenues to be in the range of $57 million to $59 million and operating income to be in the range of $4.2 million to $4.6 million. Absent the impact of acquisitions, the Company typically experiences a pattern of seasonality with net revenue and practice contribution in the first and fourth quarters of the year higher than those in the second and third quarters. The Company expects this pattern to continue and believes it is primarily due to the following factors:

-- the number of physicians the Company has on staff during the quarter, which may fluctuate based upon the timing of hires caused by the end of the academic year for graduating resident physicians and the schedule of the Internal Medicine Board exams and terminations in our existing practices; and

-- fluctuations in patient encounters which are impacted by hospital census and physician productivity and often reflect seasonality due to the higher occurrence of such illnesses as flu and pneumonia in patient populations in the first quarter.

As previously disclosed, the Company continues to invest in its infrastructure and expects to incur approximately $0.5 million to $0.6 million in incremental recurring quarterly expenses over first quarter 2008, excluding the $0.3 million related to a non-recurring IPO management bonus. In general, the incremental expense comprises continued physician leadership functions, ongoing investment in billing functions and increased stock compensation expense. The Company continues to gain operating leverage as its expenses continue to decline as a percentage of year-to-date revenues.

This outlook does not include new market acquisitions. The Company does not intend to provide information about its quarterly outlook going forward and undertakes no obligation following the date of this press release to update or revise any such statements or projections whether as a result of new information, future events, or otherwise. The Company's outlook for the second quarter is based upon assumptions that the Company's management believes reasonable, but there can be no assurance that these future results will be achieved.

About IPC The Hospitalist Company

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) is a leading national physician group practice company focused on the delivery of hospitalist medicine services. IPC's physicians and affiliated providers manage the care of hospitalized patients in coordination with primary care physicians and specialists. The Company provides its hospitalists with the comprehensive training, information technology, and management support systems necessary to improve the quality and reduce the cost of inpatient care in the facilities it serves. For more information, visit the IPC website at http://www.hospitalist.com.

IPC filed a Registration Statement on Form S-1 (including a prospectus) on June 17, 2008 with the SEC for the offering to which this communication relates. Before you decide to invest in our common stock, you should read the entire prospectus in that registration statement, including the section entitled "Risk Factors," and the other documents we have filed with the SEC for more complete information about the issuer and this offering. To review our current Registration Statement and the prospectus, click the following link on the SEC Web site at http://www.sec.gov (or if such address has changed, by reviewing our filings for the relevant date on the SEC Web site): http://www.sec.gov/Archives/edgar/data/1410471/000119312508135279/ds1.htm . Alternatively, when available, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by contacting the Credit Suisse Prospectus Department at One Madison Avenue, New York, NY 10010, (800) 221-1037, or the Jefferies & Company Prospectus Department at 520 Madison Avenue, New York, NY 10022, (888) 449-2342.

Our Central Index Key, or CIK, on the SEC Web site is 0001410471.

Safe Harbor Statement

Certain statements and information in this press release may be deemed to be "forward-looking statements" within the meaning of the Federal Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release may include, but are not limited to, those statements set forth above regarding projected operating results, revenues, expenses and seasonality. Forward-looking statements are often characterized by terminology such as "believe", "hope", "may", "anticipate", "should", "intend", "plan", "will", "expect", "estimate", "project", "positioned", "strategy" and similar expressions. Any forward-looking statements are necessarily based on a variety of estimates and assumptions which, though considered reasonable by the Company, may not be realized and are inherently subject to significant business, economic, competitive, industry, regulatory, market and financial uncertainties and contingencies, many of which are and will be beyond IPC's control. Important risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by any forward-looking statements are described in IPC's most recent Annual Report on Form 10-K, including the section titled "Risk Factors," and actual results could differ materially from those anticipated in forward-looking statements.

In particular the following risks and uncertainties may have such an impact:

-- failure to comply with complex and intensive government regulation of

our industry;

-- the ability of our affiliated hospitalists to appropriately document

services they provide;

-- the adequacy of our insurance coverage and insurance reserves;

-- our ability to recruit and retain qualified physicians;

-- our ability to successfully integrate new acquisitions;

-- the effect of changes in rates or methods of third-party reimbursement;

and

-- the high level of competition in our industry.

IPC undertakes no obligation following the date of this press release to update or revise any such statements or projections whether as a result of new information, future events, or otherwise.

Any disclaimer or other notice that may appear below is not applicable to this communication and should be disregarded. Such disclaimer or notice was automatically generated as a result of this communication being sent by Bloomberg or another email system.

Contacts:

Devra Shapiro Stephanie Carrington/Jared Hoffman

IPC The Hospitalist Company, Inc. The Ruth Group

(818) 766-3502 646-536-7017/7013

scarrington@theruthgroup.com

jhoffman@theruthgroup.com


'/>"/>
SOURCE IPC The Hospitalist Company, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Benefits of hospitalist care confirmed in new study
2. Hospitalist Physicians Help Shorten Patient Stays
3. IPC The Hospitalist Company, Inc. Prices Initial Public Offering
4. IPC The Hospitalist Company, Inc. to Present at the 2008 UBS Global Healthcare Services Conference
5. IPC The Hospitalist Company, Inc. Announces Closing of IPO and Exercise of Underwriters Over-Allotment Option
6. IPC The Hospitalist Company, Inc. to Report Fourth Quarter and Year-End 2007 Financial Results
7. IPC The Hospitalist Company Announces Board of Director Member Changes
8. IPC The Hospitalist Company Reports Fourth Quarter and Full Year 2007 Results
9. IPC The Hospitalist Company Sets 2008 Annual Meeting Date
10. IPC The Hospitalist Company Added to Russell 2000 Index
11. IPC The Hospitalist Company, Inc. to Report First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Addison, TX (PRWEB) , ... February 22, 2017 ... ... announced the launch of ProGen™ PRP, the latest innovation in the delivery of ... orthopedics, wound care, aesthetics, cardiovascular and pain management, to accelerate tissue synthesis and ...
(Date:2/22/2017)... , ... February 22, 2017 , ... The SeniorCare Investor ... 2017 Forecast —on Thursday, February 23, 2017, at 1:00 PM ET. A recording of ... part of the Interactive Webinar Series. , If you want to find out what ...
(Date:2/22/2017)... ... 22, 2017 , ... FPS is a nonprofit mental health ... in 1977, our organization was at the forefront in working with veterans with ... were evident and served as the catalyst for the establishing the agency. , ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... by itself - the Vector™ Series Multi-Cook Oven offers up to four ovens ... featuring exclusive Structured Air Technology™ for unmatched evenness in cooking. Alto-Shaam has partnered ...
(Date:2/21/2017)... ... 21, 2017 , ... Robins & Morton celebrated the grand ... Feb. 21. , The celebration began with a ribbon cutting event at 10:30 ... team and tribal leadership. , Choctaw Nation Durant Regional Medical Clinic is ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... Feb. 22, 2017  Corin Group announced today the ... used to treat patients with both a massive rotator ... The condition, known as cuff tear arthropathy, causes pain ... The Humelock Reversed Shoulder System, which was ... company based near Lyon, France , ...
(Date:2/22/2017)... Research and Markets has announced the addition of the ... to their offering. ... Dermatological conditions are one of the most ... US population suffers from at least one active skin condition. ... has remained saturated with established and generic products. However, the ...
(Date:2/22/2017)... 22, 2017 Research and Markets has ... by Drug Molecule (Biologic, Small Molecule Drugs), By Route of ... Blockers) Outlook 2022" report to their offering. ... The global psoriasis ... 2016-2022 This report provides a detailed analysis of ...
Breaking Medicine Technology: